Cargando…

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

Detalles Bibliográficos
Autores principales: Ryan, J, Tivnan, A, Fay, J, Bryan, K, Meehan, M, Creevey, L, Lynch, J, Bray, I M, O'Meara, A, Tracey, L, Davidoff, A M, Stallings, R L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461175/
http://dx.doi.org/10.1038/bjc.2012.425
_version_ 1782245049536348160
author Ryan, J
Tivnan, A
Fay, J
Bryan, K
Meehan, M
Creevey, L
Lynch, J
Bray, I M
O'Meara, A
Tracey, L
Davidoff, A M
Stallings, R L
author_facet Ryan, J
Tivnan, A
Fay, J
Bryan, K
Meehan, M
Creevey, L
Lynch, J
Bray, I M
O'Meara, A
Tracey, L
Davidoff, A M
Stallings, R L
author_sort Ryan, J
collection PubMed
description
format Online
Article
Text
id pubmed-3461175
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-34611752013-02-14 MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome Ryan, J Tivnan, A Fay, J Bryan, K Meehan, M Creevey, L Lynch, J Bray, I M O'Meara, A Tracey, L Davidoff, A M Stallings, R L Br J Cancer Corrigendum Nature Publishing Group 2012-09-25 2012-09-25 /pmc/articles/PMC3461175/ http://dx.doi.org/10.1038/bjc.2012.425 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Corrigendum
Ryan, J
Tivnan, A
Fay, J
Bryan, K
Meehan, M
Creevey, L
Lynch, J
Bray, I M
O'Meara, A
Tracey, L
Davidoff, A M
Stallings, R L
MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
title MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
title_full MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
title_fullStr MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
title_full_unstemmed MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
title_short MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
title_sort microrna-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461175/
http://dx.doi.org/10.1038/bjc.2012.425
work_keys_str_mv AT ryanj microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT tivnana microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT fayj microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT bryank microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT meehanm microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT creeveyl microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT lynchj microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT brayim microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT omearaa microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT traceyl microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT davidoffam microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome
AT stallingsrl microrna204increasessensitivityofneuroblastomacellstocisplatinandisassociatedwithafavourableclinicaloutcome